Publications by authors named "Thierry Horner"

Claim this Profile
A
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
David W Cescon, John Hilton, Serafin Morales Murilo, Rachel M Layman, Timothy Pluard, Thierry Horner

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew D J Pearson, Sara Federico, Susanne A Gatz, Michael Ortiz, Giovanni Lesa, Thierry J Horner

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Mark A Dawson, Gautam Borthakur, Brian J P Huntly, Anastasios Karadimitris, Adrian Alegre, Thierry Horner

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study.
Sophie Cousin, Jean-Yves Blay, Irene Braña Garcia, Johann S de Bono, Christophe Le Tourneau, Thierry Horner

Int J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma.
Andrew D Zelenetz, Leslie L Popplewell, Ariela Noy, Thierry J Horner, Thomas S Lin

Clin Lymphoma Myeloma Leuk· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.
Sarina A Piha-Paul, Christine L Hann, Christopher A French, Sophie Cousin, Irene Braña, Thierry Horner

JNCI Cancer Spectr· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors.
Timothy A Yap, Jane N Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Thierry Horner

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab.
Thierry J Horner, Vanessa C Williams, Patricia Giampietro, Philip A Witman, Thomas S Lin

Leuk Lymphoma· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
John P Leonard, Stephanie A Gregory, Hedy Smith, Thierry J Horner, Vanessa C Williams

Clin Lymphoma Myeloma Leuk· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
Richard L Wahl, Thierry J Horner, Thomas S Lin, Mark S Kaminski

J Nucl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab.
Robert C Quackenbush, Thierry J Horner, Vanessa C Williams, Patricia Giampietro, Thomas S Lin

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B.
Phil Oh, Thierry Horner, Halina Witkiewicz, Jan E Schnitzer

J Biol Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.
Thierry J Horner, Wi S Lai, Deborah J Stumpo, Perry J Blackshear

Mol Cell Biol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities.
Thierry J Horner, Shoji Osawa, Michael D Schaller, Ellen R Weiss

J Biol Chem· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis